CRS YSC Duet Series Recap: Entrepreneurship in Drug Delivery
Last month, CRS had the opportunity to highlight entrepreneurship in drug delivery through the CRS Young Scientists Committee (YSC) Duet series. During the session, Dominik Witzigmann, PhD—Co-Founder and President of Nanovation Therapeutics—shared insights on what it takes to translate scientific innovation into real-world impact.
The discussion focused on the journey from academic research to entrepreneurship and the challenges and opportunities scientists encounter when bringing new technologies to patients.

CRS is the home for experts dedicated to delivery science, including delivery scientists, engineers, clinicians, and technical professionals. CRS members are creating the future of delivery science and technology through fundamental delivery research, development, regulatory science, and clinical translation. Research published in CRS journals and presented during the Annual Meeting & Exposition offers a breadth of scientific knowledge covering new technologies and science in the multi-disciplinary delivery field.
